首页> 外文期刊>Statistical Methods and Applications >Most stable sample size determination in clinical trials
【24h】

Most stable sample size determination in clinical trials

机译:临床试验中最稳定的样本量测定

获取原文
获取原文并翻译 | 示例
       

摘要

This paper is devoted to robust Bayes sample size determination under the quadratic loss function. The idea behind the proposed approach is that the smaller a chosen posterior functional, the more robust the posterior inference. Such desired posterior functional has been taken, in the literature, as the range of posterior mean over a class of priors but we show that dealing with the posterior mean is not the only method leading to an optimal sample size. To provide an alternative approach, we propose implementing most stable rules into the context of sample size determination. We discuss properties of the desired most stable estimate and provide some examples in the normal model. We then compare the proposed approach with that of a recent global robustness study from both numerical and theoretical aspects. We illustrate the practical utility of our proposed method by analyzing a real data set.
机译:本文致力于在二次损失函数下确定鲁棒贝叶斯样本量。提出的方法背后的想法是,选择的后验函数越小,后验推断就越鲁棒。在文献中,此类期望的后验功能已被视为一类先验条件中的后验均值范围,但我们证明处理后验均值并不是导致最佳样本量的唯一方法。为了提供另一种方法,我们建议在确定样本量的背景下实施最稳定的规则。我们讨论所需的最稳定估计的属性,并在正常模型中提供一些示例。然后,我们从数值和理论两个方面比较了所提出的方法和最近进行的全球鲁棒性研究。我们通过分析实际数据集说明了我们提出的方法的实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号